Clinical trial
EEG Dynamics in Lennox-Gastaut Syndrome Patients Undergoing Fenfluramine Treatment
NCT07555171 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- EEG Dynamics in Lennox-Gastaut Syndrome Patients Undergoing Fenfluramine Treatment
- Lead sponsor
- University of Chicago
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- May 1, 2026
- Completion date
- April 30, 2028
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
lennox gastaut syndrome (lgs)